________________________________________________________________
İstinadlar
1. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and
meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008; 81(1):1-13.
2.
Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, Hounsome J, McKay AJ, Tudur Smith C, Marson AG.
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database of Systematic
Reviews 2016, Issue 11. Art. No.: CD010224
3. Foch C, Araujo M, Weckel A, Damase-Michel C, Montastruc JL, Benevent J, et al. In utero drug exposure and hearing impairment
in 2-year-old children A case-control study using the EFEMERIS database. Int J Pediatr Otorhinolaryngol. 2018 Oct;113: 192-7.
4. Bromley RL, Mawer G, Love J, Kelly J, Purdy L, McEwan L et al. Early cognitive development in children
born to women with
epilepsy: a prospective report. Epilepsia 2010 October; 51(10):2058-65.
5. Cummings et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis
Child 2011;96: 643-647
6. Meador K et al. Cognitive Function at 3 years of age after fetal exposure to antiepileptic drugs. NEJM 2009; 360 (16): 1597- 1605
7. Thomas S.V et al. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy and Behaviour 2008
(13):229-236
8. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J,Kalayjian LA, Kanner A, Liporace JD, Pennell PB,
Privitera M, Loring DW; NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD
study): a prospective observational study. Lancet Neurol. 2013 Mar; 12(3):244-52
9. Christensen J et al. Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism. JAMA 2013;
309(16):1696-1703
10.Christensen J,
Pedersen L, Sun Y, Dreier JW, Brikell I, Dalsgaard S. Association of prenatal exposure
to valproate and other
antiepileptic drugs with risk for attention deficit/hyperactivity disorder in offspring. JAMA New Open. 2019;2(1): e186606
11 Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, de Jong-van den Berg LT. Does folic acid use decrease the risk for spina bifida
after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):803-7.
12 Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical
practice guidelines for
mood disorders. Australian and New Zealand J. Psychiatry 2015, Vol. 49(12) 1-185.
13 Minutes and answers from the SAG Psychiatry meeting on Valproate- EMA/679681/2017